Monday, 8 July 2024
  
Login

Australia's most trusted
source of pharma news

Monday, 08 July 2024
Listen to this story 
News

2023's final PBS listing winners

Posted 1 December 2023 PM 

Six pharmas have scored the last PBS listings for this year - all adding new indications to their already big drugs - while other companies vying for government subsidy will have to wait until 2024.

The expansions, which came into effect today (Friday) cover cancer drugs, including three checkpoint inhibitors and treatments for inflammatory diseases, such as Crohn's disease (CD) and arthritis.

To see the whole article, please login

Popular

Drugs stuck in PBS listing limbo
Omnichannel flops in engaging Drs
Next big meds: the countdown is on
Company on Aussie hiring spree
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (24)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (8)

Other (21)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2024 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home